Inmed Pharmaceuticals INC. (INM) SEC Filings — 2024
34 SEC filings for Inmed Pharmaceuticals INC. (INM) in 2024.
Filings
- InMed Pharmaceuticals Files S-1/A Amendment — S-1/A · Dec 30, 2024
- InMed Pharmaceuticals Files S-1 for Potential Offering — S-1 · Dec 23, 2024
- Ares Management to Acquire InMed Pharmaceuticals for $100M — 8-K · Dec 19, 2024
- InMed Pharmaceuticals Inc. Files 8-K: Material Agreement & Equity Sales — 8-K · Dec 18, 2024
- InMed Pharmaceuticals Files 8-K — 8-K · Nov 20, 2024
- InMed Pharmaceuticals Files 8-K — 8-K · Nov 15, 2024
- InMed Pharmaceuticals Files Q3 2024 Report — 10-Q · Nov 14, 2024
- Inmed Pharmaceuticals INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- InMed Pharmaceuticals Files 8-K: Rights, Reg FD, and More — 8-K · Nov 12, 2024
- Inmed Pharmaceuticals INC. SC 13G Filing — SC 13G · Nov 12, 2024
- InMed Pharmaceuticals Faces Delisting Notice — 8-K · Nov 5, 2024
- InMed Pharmaceuticals Files 2024 Proxy Statement — DEF 14A · Oct 28, 2024
- InMed Pharmaceuticals Files 8-K — 8-K · Oct 24, 2024
- InMed Pharmaceuticals to be Acquired by Capstone Development — 8-K · Oct 23, 2024
- InMed Pharmaceuticals Inc. Files 2024 Annual Report — 10-K · Sep 30, 2024
- InMed Pharmaceuticals Files 8-K — 8-K · Sep 26, 2024
- InMed Pharmaceuticals Faces Delisting Concerns — 8-K · Sep 20, 2024
- InMed Pharmaceuticals Files 8-K — 8-K · Aug 21, 2024
- InMed Pharmaceuticals to Acquire BayMedica for $10M — 8-K · Aug 20, 2024
- InMed Pharmaceuticals Files 8-K — 8-K · Jul 30, 2024
- InMed Pharmaceuticals Inc. Files 8-K for Material Agreement — 8-K · Jun 28, 2024
- InMed Pharmaceuticals Acquires BayMedica for $10M — 8-K · Jun 11, 2024
- InMed Pharmaceuticals Inc. Files 10-Q for Period Ended March 31, 2024 — 10-Q · May 14, 2024
- InMed Pharmaceuticals Files 8-K — 8-K · Apr 18, 2024
- InMed Pharmaceuticals Acquires Canna-Core for $1.5M — 8-K · Apr 16, 2024
- InMed Pharmaceuticals Files 8-K — 8-K · Apr 5, 2024
- InMed Pharmaceuticals Faces Delisting Concerns — 8-K · Mar 20, 2024
- InMed Pharmaceuticals Files 8-K for Feb 13 Event — 8-K · Feb 14, 2024
- Inmed Pharmaceuticals INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- InMed Pharmaceuticals Inc. Files 10-Q for Period Ended December 31, 2023 — 10-Q · Feb 13, 2024
- InMed Pharma Reports Leadership Changes & Comp Arrangements — 8-K · Feb 9, 2024
- InMed Pharma Confirms Nasdaq Listing for Common Shares — 8-K · Jan 19, 2024
- InMed Pharma Files Routine 8-K, Confirms Address & Contact Info — 8-K · Jan 16, 2024
- Sabby Volatility Fund Discloses 524,972 Share Stake in InMed Pharma — SC 13G · Jan 4, 2024